Log in to save to my catalogue

Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme

Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7918566

Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme

About this item

Full title

Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme

Publisher

Switzerland: MDPI

Journal title

International journal of molecular sciences, 2021-02, Vol.22 (4), p.1831

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI

More information

Scope and Contents

Contents

Glioblastoma multiforme (GBM) is amongst the deadliest of human cancers, with a median survival rate of just over one year following diagnosis. Characterized by rapid proliferation and diffuse infiltration into the brain, GBM is notoriously difficult to treat, with tumor cells showing limited response to existing therapies and eventually developing...

Alternative Titles

Full title

Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7918566

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7918566

Other Identifiers

ISSN

1422-0067

E-ISSN

1422-0067

DOI

10.3390/ijms22041831

How to access this item